ELAHERE 5 MG/ML SOL INJ DIL CT FA VD TRANS X 20 ML
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1986000220019 -
GGREM
543725110005801 -
Código de barras
8054083029030
O que a fonte publica
- Detentor do registro
- ABBVIE FARMACÊUTICA LTDA.
- Princípios ativos
- MIRVETUXIMABE SORAVTANSINA
- Embalagem
- 5 MG/ML SOL INJ DIL CT FA VD TRANS X 20 ML
- Tipo de produto
- Biológico
- Classe terapêutica
- L1G9 - ANTICORPOS MONOCLONAIS ANTINEOPLÁSICOS, OUTROS
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "ELAHERE 5 MG/ML SOL INJ DIL CT FA VD TRANS X 20 ML",
"holder": "ABBVIE FARMACÊUTICA LTDA.",
"stripe": null,
"barcodes": [
"8054083029030"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "543725110005801",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "15.800.545/0001-50",
"priceRegime": "Regulado",
"productName": "ELAHERE",
"productType": "Biológico",
"hospitalOnly": false,
"presentation": "5 MG/ML SOL INJ DIL CT FA VD TRANS X 20 ML",
"sourceStatus": null,
"supplyRegime": null,
"factoryPrices": {
"icms-0": "21029.00",
"icms-12": "23896.60",
"icms-17": "25336.14",
"icms-18": "25645.12",
"icms-19": "25961.73",
"icms-20": "26286.25",
"icms-21": "26618.99",
"icms-22": "26960.25",
"icms-23": "27310.38",
"icms-17.5": "25489.69",
"icms-19.5": "26122.98",
"icms-20.5": "26451.58",
"icms-22.5": "27134.20",
"icms-12-alc": "21336.25",
"icms-17-alc": "22621.55",
"icms-18-alc": "22897.43",
"icms-19-alc": "23180.10",
"icms-20-alc": "23469.86",
"icms-21-alc": "23766.95",
"icms-22-alc": "24071.64",
"icms-23-alc": "24384.26",
"withoutTaxes": "18775.89",
"icms-17.5-alc": "22758.66",
"icms-19.5-alc": "23324.08",
"icms-20.5-alc": "23617.46",
"icms-22.5-alc": "24226.94"
},
"pisCofinsList": "Negativa",
"substanceText": "MIRVETUXIMABE SORAVTANSINA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "28209.65",
"icms-12": "32056.44",
"icms-17": "33987.53",
"icms-18": "34402.02",
"icms-19": "34826.74",
"icms-20": "35262.07",
"icms-21": "35708.43",
"icms-22": "36166.22",
"icms-23": "36635.90",
"icms-17.5": "34193.51",
"icms-19.5": "35043.05",
"icms-20.5": "35483.85",
"icms-22.5": "36399.56",
"icms-12-alc": "29496.11",
"icms-17-alc": "31272.97",
"icms-18-alc": "31654.35",
"icms-19-alc": "32045.13",
"icms-20-alc": "32445.70",
"icms-21-alc": "32856.41",
"icms-22-alc": "33277.63",
"icms-23-alc": "33709.81",
"withoutTaxes": "25956.57",
"icms-17.5-alc": "31462.51",
"icms-19.5-alc": "32244.17",
"icms-20.5-alc": "32649.75",
"icms-22.5-alc": "33492.32"
},
"invalidBarcodes": [],
"activeSubstances": [
"MIRVETUXIMABE SORAVTANSINA"
],
"therapeuticClass": "L1G9 - ANTICORPOS MONOCLONAIS ANTINEOPLÁSICOS, OUTROS",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1986000220019",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"therapeuticClassCode": "L1G9",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:543725110005801"